Integrated Diagnostics Holdings plc
IDGXF
$0.64
$0.046.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -6.64% | 10.78% | -3.90% | -4.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -6.64% | 10.78% | -3.90% | -4.36% |
| Cost of Revenue | -- | -10.03% | 8.15% | -5.34% | -5.54% |
| Gross Profit | -- | -0.92% | 15.27% | -1.41% | -2.36% |
| SG&A Expenses | -- | -7.70% | 43.60% | -17.30% | -17.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -351.39% | -4,779.19% | -203.76% | -2,027.37% |
| Total Operating Expenses | -- | -11.08% | 4.88% | -8.71% | -8.59% |
| Operating Income | -- | 12.22% | 37.71% | 20.34% | 17.56% |
| Income Before Tax | -- | -10.78% | 85.87% | 2.34% | 68.55% |
| Income Tax Expenses | -- | -1.05% | 58.62% | -22.84% | 23.44% |
| Earnings from Continuing Operations | -- | -15.47% | 101.41% | 15.89% | 105.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -45.90% | 89.72% | 97.49% | 11.01% |
| Net Income | -- | -17.68% | 100.46% | 20.41% | 90.99% |
| EBIT | -- | 12.22% | 37.71% | 20.34% | 17.56% |
| EBITDA | -- | 3.85% | 23.16% | 10.28% | 7.83% |
| EPS Basic | -- | -15.63% | 104.68% | 21.63% | 91.79% |
| Normalized Basic EPS | -- | -10.28% | 71.74% | -7.69% | 18.93% |
| EPS Diluted | -- | -15.63% | 104.68% | 21.63% | 91.79% |
| Normalized Diluted EPS | -- | -10.28% | 71.74% | -7.69% | 18.93% |
| Average Basic Shares Outstanding | -- | -1.84% | -1.56% | -0.78% | 0.00% |
| Average Diluted Shares Outstanding | -- | -1.84% | -1.56% | -0.78% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |